Richard N. Levy, Director at UNIGENE LABORATORIES INC (UGNE), bought 245,550 shares at $0.65 ($163K) on 2010-08-27, disclosed to the SEC on 2010-08-31.
Open-market purchase of $163k UGNE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.65 | 176,633 | $115K | 70.6% |
| 2 | $0.68 | 18,917 | $13K | 7.9% |
| 3 | $0.70 | 50,000 | $35K | 21.5% |
| Total | $0.66 avg | 245,550 | $163K | 100% |
| Filing → |
| BKKT | SELL | 2023-12-20 | $956K | — | Filing → |
| BKKT | SELL | 2023-12-19 | $581K | — | Filing → |
| BKKT | SELL | 2023-12-06 | $165K | — | Filing → |